Nadia Dawn Ali, MD
Hematology
Headshot of Nadia Dawn Ali, MD

Nadia Dawn Ali, MD

Hematology
Accepting new patients
Sees patients age 18 and up
Penn Blood Disorders Center
Headshot of Nadia Dawn Ali, MD
Penn Medicine Provider

About me

  • Associate Professor of Clinical Medicine (Hematology-Oncology)

My education and training

  • Southern Illinois UniversityMedical School
  • Montefiore Medical CenterResidency
  • Robert Wood Johnson University HospitalFellowship

Spoken languages

English
English

Reviews

Average Rating

86 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
She is exceptional easy to talk to she is very opened minded
Anonymous
August 2026
dr ali was able to start treatment on a disorder that would have serious effects for my future and result in grave disability
Anonymous
July 2026
great provider!
Anonymous
May 2026
i had a very positive appointment with dr. ali.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Ali is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Emma Lewis, Susanna Ostrowski1, Victoria C. Chinaka, Nadia Ali, Aaron Cheng, Scott Peslak, Kandace Gollomp, Andrea Roe Sex- and hormone-associated differences in inflammatory protein expression in sickle cell disease , Blood, abs26-5187, 148(19): 2026


Braun E, McVay K, Koelper N, Ali N, Gollomp K, Roe AH Induced and spontaneous abortion outcomes among individuals with sickle cell disease. Contraception. , Contraception, 111052: 2025


Ewy J, Senapati S, Ali ND, Gracia CR. Special considerations in assisted reproductive technology for patients with hematologic disease. , Fertil Steril., 124(2): 2025,200-211


Jian Jeff Fu , Anjali Seth, Nadia Ali, Ashwin Chandar, Ashish Bains. ALK-positive Large B-Cell Lymphoma With Multiple Epithelial Antigen Expression and PABPC1::ALK Fusion : A Novel Molecular Alteration , Am J Surg Pathol, 47(8): 2023,950-954


Stack A, Black S, Gupta B,Zhao H, Ali N. Correlation between the 4T Score, Enzyme-Linked Immunosorbent Assay and Serotonin Release Assay for Diagnosis of Heparin Induced Thrombocytopenia. , American Society of Hematology Annual Meeting, New Orleans, LA.: 2022


Berardi, GG; Rosario Vega, JA; Ali, N. Can you Spot the Schistocytes? Pernicious Anemia with Severe B12 Deficiency Presenting as Hemolytic Anemia. , Society of Hospital Medicine Conference, Philadelphia, PA.: 2021


Yousef I, Desai PB, Sehgal S, Gupta R, Gordon M, Weir M, Ali N, Criner GJ, Rao AK, Rali P. Thromboelastography (TEG) in COVID-19 Patients - Not All Hypercoagulable. , American Thoracic Society International Conference, Virtual Meeting.: 2021


Rali P, O’Corragain O, Oresanya L, Yu D, Sheriff O, Weiss R, Myers C, Desai P, Ali N, Stack A, Bromberg M, Lubitz A, Panaro J, Bashir R, Lakhter V, Caricchio R, Gupta R, Dass C, Maruti K, Lu X, Rao AK, Cohen G, Criner G, Choi E. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center , J Vasc Surg Venous Lymphat Disord, 9(3): 2021,585-591


Stack A, Ali N, Khan N. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. , J Cell Immunol, 2(3): 2020,80-89


Ali ND and Bains A. Triple hit B-cell lymphoma with diffuse kidney involvement sparing the glomeruli. , Blood, 134(10): 2019,842. doi: 10.1182/blood.2019001752.